DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

Influenza virus remains a significant public health threat despite innovative vaccines and antiviral drugs. A major limitation to current vaccinations and therapies against influenza virus is pathogenic diversity generated by shift and drift. A simple, cost-effective passive immunization strategy vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Sarah T. C., Kallewaard, Nicole L., Benjamin, Ebony, Wachter-Rosati, Leslie, McAuliffe, Josephine M., Patel, Ami, Smith, Trevor R. F., Schultheis, Katherine, Park, Daniel H., Flingai, Seleeke, Wise, Megan C., Mendoza, Janess, Ramos, Stephanie, Broderick, Kate E., Yan, Jian, Humeau, Laurent M., Sardesai, Niranjan Y., Muthumani, Kar, Zhu, Qing, Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627301/
https://www.ncbi.nlm.nih.gov/pubmed/29263874
http://dx.doi.org/10.1038/s41541-017-0020-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627301/
https://www.ncbi.nlm.nih.gov/pubmed/29263874
http://dx.doi.org/10.1038/s41541-017-0020-x

Ejemplares similares